| Financial Year |
March 31 2023 |
| Monetary Funds |
697,044,980.04 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,547,502,982.33 |
| Advances to Suppliers |
26,152,104.99 |
| Other Receivables |
355,736,399.42 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
45,823,136.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
115,417,676.06 |
| Total Current Assets |
3,695,446,210.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
112,144,380.43 |
| Investment Properties |
381,455,857.80 |
| Fixed Assetes |
776,036,634.17 |
| Under-construction Projects |
8,904,891.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,590,800,388.66 |
| R&D expenses |
-- |
| Goodwill |
4,401,587.97 |
| Long-Term Deferred and Prepaid Expenses |
118,192,316.76 |
| Deferred Income Tax Assets |
57,375,174.25 |
| Other Non-Current Assets |
340,012,709.35 |
| Sub-Total of Non-Current Assets |
3,456,985,361.29 |
| Total Assets |
7,152,431,571.37 |
| Short-Term Loans |
1,856,560,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
770,839,986.38 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
252,292,947.69 |
| Taxes Payable |
89,817,637.10 |
| Interest Payable |
-- |
| Dividend Payable |
2,825,283.67 |
| Other payables |
66,998,925.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
118,376,175.22 |
| Other Current Liabilities |
1,234,002.30 |
| Sub-Total of Current Liabilities |
3,166,282,785.52 |
| Long-term Loans |
1,011,097,461.36 |
| Bonds Payable |
444,871,767.85 |
| Long-Term Accounts Payable |
87,227,193.80 |
| Special Payable |
-- |
| Estimatied Liabilities |
110,561,366.13 |
| Deferred Income Tax Liabilities |
18,697,765.22 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,719,389,542.35 |
| Total Liabilities |
4,885,672,327.87 |
| Paid-In Capital(Or Share Stock) |
408,664,950.00 |
| Capital Surplus |
261,141,354.56 |
| Surplus Reserve |
74,198,935.54 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,248,115,317.93 |
| Minority Stockholder's Interest |
246,405,152.72 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,020,354,090.78 |
| Owner's Equity（Stockholder's Equity） |
2,266,759,243.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,152,431,571.37 |
